Neurologix (Neurologix) Total Stockholders Equity : $-8.66 Mil (As of Jun. 2011)

View and export this data going back to . Start your Free Trial

What is Neurologix Total Stockholders Equity?

Neurologix's Total Stockholders Equity for the quarter that ended in Jun. 2011 was $-8.66 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Neurologix's Book Value per Share for the quarter that ended in Jun. 2011 was $-0.31. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Neurologix's Debt-to-Equity for the quarter that ended in Jun. 2011 was -0.70.

Neurologix Total Stockholders Equity Historical Data

The historical data trend for Neurologix's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurologix Total Stockholders Equity Chart

Neurologix Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Total Stockholders Equity

Get a 7-Day Free Trial

10.85

20.17

19.27

5.38

-4.16

Neurologix Quarterly Data
	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11
Total Stockholders Equity	Get a 7-Day Free Trial															-2.15	-4.32	-4.16	-6.14	-8.66

Neurologix (GREY:NRGXQ) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Neurologix's Book Value per Share for the quarter that ended in Jun. 2011 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-8.664	-	0.101)	/	27.9977
	=	-0.31

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Neurologix's Debt-to-Equity for the quarter that ended in Jun. 2011 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.078	+	0)	/	-8.664
	=	-0.70

Neurologix Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Neurologix's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurologix (Neurologix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurologix Inc (GREY:NRGXQ) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Bridge Plaza, Fort Lee, NJ, USA, 07024

Website

http://www.neurologix.net

Neurologix Inc is a development stage company that is engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other innovative therapies.

Neurologix (Neurologix) Headlines

No Headlines